表紙
市場調査レポート

アレルギー診断の世界市場 〜2021年:製品 (測定キット、免疫測定分析装置、ルミノメーター、消耗品、サービス)、アレルゲン、検査方法、エンドユーザー別の予測

Allergy Diagnostics Market by Product (Assay Kits, Instruments (Immunoassay Analyzer, Luminometer), Consumables, Services), Allergen (Food, Inhaled, Drug), Tests (In Vivo, In Vitro), End User (Hospital, Diagnostic Laboratory) - Forecast to 2021

発行 MarketsandMarkets 商品コード 321266
出版日 ページ情報 英文 193 Pages
即納可能
価格
本日の銀行送金レート: 1USD=106.02円で換算しております。
Back to Top
アレルギー診断の世界市場 〜2021年:製品 (測定キット、免疫測定分析装置、ルミノメーター、消耗品、サービス)、アレルゲン、検査方法、エンドユーザー別の予測 Allergy Diagnostics Market by Product (Assay Kits, Instruments (Immunoassay Analyzer, Luminometer), Consumables, Services), Allergen (Food, Inhaled, Drug), Tests (In Vivo, In Vitro), End User (Hospital, Diagnostic Laboratory) - Forecast to 2021
出版日: 2016年06月13日 ページ情報: 英文 193 Pages
概要

世界のアレルギー診断関連の市場規模は、2016年には29億8000万米ドル 2021年には 53億4000万米ドルと、12.4%のCAGR (複合年間成長率) で拡大する、と推計されています。市場成長の主な促進要因として、アレルギー疾患患者の増加のほか、環境汚染の拡大、医療費の増大、米国の医療保険制度改革などが挙げられます。製品別に見ると、検査用試薬キットが今後急速に成長する見通しです。

当レポートでは、アレルギー診断の世界市場に注目し、アレルゲン (アレルギー誘発物質)、製品・サービス、検査方法、エンドユーザー、地域の別にその推移を予測するほか、市場の現況、発展への影響要因、競合環境、有力企業などについて最新の調査・分析情報をまとめています。

第1章 イントロダクション

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 特記すべき考察点

第5章 市場概要

  • イントロダクション
  • 市場セグメンテーション
  • 市場動態
    • 推進要因
      • アレルギー疾患の発症率の高さと経済的負担の主さ
      • 環境汚染の拡大
      • 医療費拡大
      • 米国における医療保険へのアクセス改善
    • 抑制要因
      • 医療機器に対する厳格な規制
      • アレルギー疾患に対する認知度の低さ
      • 高額な設備投資の必要性
      • 市場集中度の高さ:新規参入企業に対する市場障壁
    • 機会
      • アジア市場の急成長の機会
    • 動向
      • アレルギー診断装置の応答時間の速さと処理能力の高さ
      • 検査試薬レンタル契約の登場
      • 迅速な判定
      • 高い処理能力

第6章 産業動向

  • イントロダクション
  • 市場指標
    • アレルギー疾患の発症率の高さと経済的負担の主さ
  • 産業動向
    • 応答時間の速さと処理能力の高さ
  • Porterのファイブフォース分析
  • バリューチェーン分析
  • 主な影響
  • 戦略的ベンチマーキング

第7章 アレルギー診断市場:製品別

  • イントロダクション
  • 診断キット
  • 診断装置
    • 免疫測定分析装置
    • ルミノメーター (照度計)
    • ELISA (酵素結合免疫吸着法) 分析装置
    • その他
  • サービス

第8章 アレルギー診断市場:アレルゲン別

  • イントロダクション
  • 吸入アレルゲン
  • 食品アレルゲン
  • 薬物アレルゲン
  • その他のアレルゲン

第9章 アレルギー診断市場:検査方法

  • イントロダクション
  • 生体内 (in vivo) 検査
  • 体外 (in vitro) 検査

第10章 アレルギー診断市場:エンドユーザー別

  • イントロダクション
  • 診断試験所
  • 病院
  • 学術研究機関
  • その他

第11章 アレルギー診断市場:地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州諸国
  • アジア
    • 中国
    • 日本
    • インド
    • その他アジア諸国
  • その他の地域 (ROW)
    • 南米・中米・カリブ海地域
    • 太平洋・オセアニア
    • アフリカ

第12章 競合環境

  • イントロダクション
  • 戦略の概要
  • 市場シェア分析
  • 競合状況および動向
    • 新製品発売
    • 事業拡張
    • 協定、提携、協力
    • 企業買収
    • その他の展開

第13章 企業プロファイル (概要、製品・サービス、戦略・分析・考察、近年の動向、MnMの見解)

  • イントロダクション
  • BIOMERIEUX
  • DANAHER CORPORATION
  • HITACHI CHEMICAL DIAGNOSTICS, INC.
  • SIEMENS AG
  • THERMO FISHER SCIENTIFIC, INC.
  • HOB BIOTECH GROUP
  • HYCOR BIOMEDICAL
  • INCOLN DIAGNOSTICS, INC.
  • OMEGA DIAGNOSTICS GROUP PLC
  • STALLERGENES GREER

第14章 付録

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: MD 2955

The allergy diagnostics market is expected to reach USD 5.34 billion by 2021 from USD 2.98 billion in 2016, at a CAGR of 12.4%. The global allergy diagnostics market is segmented based on product, allergen, test, end user, and region. The assay kits segment is expected to register the highest growth rate in the allergy diagnostics market, by product, during the forecast period. The high growth in this segment is attributed to the increase in number of allergens and increasing healthcare expenditure worldwide.

Based on end users, the allergy diagnostics market is segmented into diagnostic laboratories, hospitals, academic research institutes, and other end users. The diagnostic laboratories segment is expected to account for the largest share of the market in 2016. Increasing prevalence of allergic diseases and the need for developing new therapies will drive the growth of this market.

Geographically, the allergy diagnostics market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). Growth in the North American region is primarily driven by the rising aging population and benefits for youth in health insurance.

The major factors contributing to the growth of the allergy diagnostics market include increasing incidences of allergic diseases, rising environmental pollution, increasing healthcare expenditure, and increase in access to medical insurance in the U.S. On the other hand, stringent regulatory policies for validation of medical devices and the highly consolidated market which creates an obstacle for entry of small players are the major factors restraining the growth of this market.

Apart from comprehensive geographic and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise the product portfolios, developments, and strategies adopted by the market players to maintain and increase their shares in the market. The above-mentioned market research data, current market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output in order to remain successful in the allergy diagnostics market.

The major players in the allergy diagnostics market include bioMerieux SA (France), Danaher Corporation (U.S.), Hitachi Chemical Diagnostics, Inc. (Japan), Siemens AG (Germany), Thermo Fisher Scientific, Inc. (U.S.), Stallergenes Greer (France), HOB Biotech Group Co., Ltd (China), HYCOR Biomedical (U.S.), Lincoln Diagnostics, Inc. (U.S.), and Omega Diagnostics Group PLC (U.K.).

Reasons to Buy the Report:

This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the allergy diagnostics market. The report analyses the allergy diagnostics market by product, allergen, test, end user, and region
  • Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and new product launches in the allergy diagnostics market
  • Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the allergy diagnostics market
  • Market Development: Comprehensive information about emerging markets. This report analyses the market for various allergy diagnostics market products across geographies
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the allergy diagnostics market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
    • 1.2.1. MARKETS COVERED
    • 1.2.2. YEARS CONSIDERED FOR THE STUDY
  • 1.3. CURRENCY
  • 1.4. LIMITATIONS
  • 1.5. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. SECONDARY DATA
    • 2.1.1. KEY DATA FROM SECONDARY SOURCES
  • 2.2. PRIMARY DATA
    • 2.2.1. KEY DATA FROM PRIMARY SOURCES
  • 2.3. MARKET SIZE ESTIMATION
    • 2.3.1. BOTTOM-UP APPROACH
    • 2.3.2. TOP-DOWN APPROACH
  • 2.4. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.5. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

  • 3.1. INTRODUCTION
  • 3.2. CURRENT SCENARIO
  • 3.3. FUTURE OUTLOOK
  • 3.4. CONCLUSION

4. PREMIUM INSIGHTS

  • 4.1. ALLERGY DIAGNOSTICS MARKET OVERVIEW
  • 4.2. LIFE CYCLE ANALYSIS, BY REGION

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET SEGMENTATION
  • 5.3. MARKET DYNAMICS
    • 5.3.1. DRIVERS
      • 5.3.1.1. High Incidences and Large Economic Burden of Allergic Diseases
      • 5.3.1.2. Rising Environmental Pollution
      • 5.3.1.3. Increasing Healthcare Expenditure
      • 5.3.1.4. Increase in Access to Medical Insurance in the U.S.
    • 5.3.2. RESTRAINTS
      • 5.3.2.1. Stringent Regulations for Medical Devices
      • 5.3.2.2. Lack of Awareness about Allergic Diseases
      • 5.3.2.3. High Capital Requirements
      • 5.3.2.4. High Degree of Consolidation Acts as an Entry Barrier for New Entrants
    • 5.3.3. OPPORTUNITIES
      • 5.3.3.1. Asian Market Presents High-Growth Opportunities
    • 5.3.4. TRENDS
      • 5.3.4.1. Quick Turnaround Times and High Throughput of Allergy Diagnostic Systems
      • 5.3.4.2. Rise in Reagent Rental Agreements

6. INDUSTRY INSIGHTS

  • 6.1. INTRODUCTION
  • 6.2. MARKET INDICATORS
    • 6.2.1. HIGH INCIDENCE AND LARGE ECONOMIC BURDEN OF ALLERGIC DISEASES
  • 6.3. INDUSTRY TRENDS
    • 6.3.1. QUICK TURNAROUND TIMES AND HIGH THROUGHPUT
  • 6.4. PORTER'S FIVE FORCES ANALYSIS
    • 6.4.1. THREAT FROM NEW ENTRANTS
    • 6.4.2. THREAT FROM SUBSTITUTES
    • 6.4.3. BARGAINING POWER OF BUYERS
    • 6.4.4. BARGAINING POWER OF SUPPLIERS
    • 6.4.5. INTENSITY OF RIVALRY
  • 6.5. VALUE CHAIN ANALYSIS
  • 6.6. KEY INFLUENCERS
  • 6.7. STRATEGIC BENCHMARKING

7. ALLERGY DIAGNOSTICS MARKET, BY PRODUCT

  • 7.1. INTRODUCTION
  • 7.2. ASSAY KITS
  • 7.3. INSTRUMENTS
    • 7.3.1. IMMUNOASSAY ANALYZERS
    • 7.3.2. LUMINOMETERS
    • 7.3.3. ELISA ANALYZERS
    • 7.3.4. OTHER INSTRUMENTS
  • 7.4. SERVICES

8. ALLERGY DIAGNOSTICS MARKET, BY ALLERGENS

  • 8.1. INTRODUCTION
  • 8.2. INHALED ALLERGENS
  • 8.3. FOOD ALLERGENS
  • 8.4. DRUG ALLERGENS
  • 8.5. OTHER ALLERGENS

9. ALLERGY DIAGNOSTICS MARKET, BY TEST

  • 9.1. INTRODUCTION
  • 9.2. IN VIVO TESTS
  • 9.3. IN VITRO TESTS

10. ALLERGY DIAGNOSTICS MARKET, BY END USER

  • 10.1. INTRODUCTION
  • 10.2. DIAGNOSTIC LABORATORIES
  • 10.3. HOSPITALS
  • 10.4. ACADEMIC RESEARCH INSTITUTES
  • 10.5. OTHER END USERS

11. ALLERGY DIAGNOSTICS MARKET, BY REGION

  • 11.1. INTRODUCTION
  • 11.2. NORTH AMERICA
    • 11.2.1. U.S.
    • 11.2.2. CANADA
  • 11.3. EUROPE
    • 11.3.1. GERMANY
    • 11.3.2. U.K.
    • 11.3.3. FRANCE
    • 11.3.4. ITALY
    • 11.3.5. SPAIN
    • 11.3.6. REST OF EUROPE (ROE)
  • 11.4. ASIA
    • 11.4.1. CHINA
    • 11.4.2. JAPAN
    • 11.4.3. INDIA
    • 11.4.4. REST OF ASIA (ROA)
  • 11.5. REST OF THE WORLD (ROW)
    • 11.5.1. SOUTH AMERICA, CENTRAL AMERICA & THE CARIBBEAN
    • 11.5.2. PACIFIC AND OCEANIA
    • 11.5.3. AFRICA

12. COMPETITIVE LANDSCAPE

  • 12.1. INTRODUCTION
  • 12.2. STRATEGIC OVERVIEW
  • 12.3. MARKET SHARE ANALYSIS
  • 12.4. COMPETITIVE SITUATION AND TRENDS
    • 12.4.1. NEW PRODUCT LAUNCHES
    • 12.4.2. EXPANSIONS
    • 12.4.3. AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS
    • 12.4.4. ACQUISITIONS
    • 12.4.5. OTHER DEVELOPMENTS

13. COMPANY PROFILES (Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*

  • 13.1. INTRODUCTION
  • 13.2. BIOMERIEUX
  • 13.3. DANAHER CORPORATION
  • 13.4. HITACHI CHEMICAL DIAGNOSTICS, INC.
  • 13.5. SIEMENS AG
  • 13.6. THERMO FISHER SCIENTIFIC, INC.
  • 13.7. HOB BIOTECH GROUP
  • 13.8. HYCOR BIOMEDICAL
  • 13.9. LINCOLN DIAGNOSTICS, INC.
  • 13.10. OMEGA DIAGNOSTICS GROUP PLC
  • 13.11. STALLERGENES GREER

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

14. APPENDIX

  • 14.1. INSIGHTS OF INDUSTRY EXPERTS
  • 14.2. DISCUSSION GUIDE
  • 14.3. OTHER DEVELOPMENTS
  • 14.4. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.5. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 14.6. AVAILABLE CUSTOMIZATIONS
  • 14.7. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: THE ECONOMIC BURDEN OF ALLERGIES
  • TABLE 2: INCREASING HEALTHCARE EXPENDITURE IS AN IMPORTANT DRIVER FOR THE ALLERGY DIAGNOSTICS MARKET
  • TABLE 3: STRINGENT REGULATORY POLICIES FOR VALIDATION OF DEVICES PRODUCTS TO RESTRICT MARKET GROWTH
  • TABLE 4: ASIA PRESENTS HIGH-GROWTH OPPORTUNITIES IN THE ALLERGY DIAGNOSTICS MARKET
  • TABLE 5: HIGH-THROUGHPUT TECHNOLOGIES IS A MAJOR TREND OBSERVED IN THE ALLERGY DIAGNOSTICS MARKET
  • TABLE 6: ECONOMIC BURDEN OF ALLERGIES BOOSTING THE GROWTH OF ALLERGY DIAGNOSTICS MARKET
  • TABLE 7: MARKET DEVELOPMENTS BETWEEN 2012 AND 2016
  • TABLE 8: ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 9: ALLERGY DIAGNOSTICS ASSAY KITS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 10: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 11: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 12: ALLERGY DIAGNOSTICS IMMUNOASSAY ANALYZERS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 13: ALLERGY DIAGNOSTICS LUMINOMETERS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 14: ALLERGY DIAGNOSTICS ELISA ANALYZERS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 15: ALLERGY DIAGNOSTICS OTHER INSTRUMENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 16: ALLERGY DIAGNOSTICS SERVICES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 17: ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGENS, 2014-2021 (USD MILLION)
  • TABLE 18: INHALED ALLERGEN MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 19: ALLERGY DIAGNOSTICS MARKET SIZE FOR INHALED ALLERGENS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 20: FOOD ALLERGEN MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 21: ALLERGY DIAGNOSTICS MARKET SIZE FOR FOOD ALLERGENS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 22: ALLERGY DIAGNOSIS MARKET SIZE FOR DRUG ALLERGENS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 23: ALLERGY DIAGNOSIS MARKET SIZE FOR OTHER ALLERGENS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 24: ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2014-2021 (USD MILLION)
  • TABLE 25: IN VIVO ALLERGY TESTING MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 26: IN VITRO ALLERGY TESTING MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 27: ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 28: ALLERGY DIAGNOSTICS MARKET SIZE FOR DIAGNOSTIC LABORATORIES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 29: ALLERGY DIAGNOSTICS MARKET SIZE FOR HOSPITALS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 30: ALLERGY DIAGNOSTICS MARKET SIZE FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 31: ALLERGY DIAGNOSTICS MARKET SIZE FOR OTHER END USERS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 32: ALLERGY DIAGNOSTICS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 33: NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 34: NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 35: NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2014-2021 (USD MILLION)
  • TABLE 36: NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGEN, 2014-2021 (USD MILLION)
  • TABLE 37: NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 38: U.S.: ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 39: U.S.: ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 40: CANADA: ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 41: CANADA: ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 42: EUROPE: ALLERGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 43: EUROPE: ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 44: EUROPE: ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2014-2021 (USD MILLION)
  • TABLE 45: EUROPE: ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGEN, 2014-2021 (USD MILLION)
  • TABLE 46: EUROPE: ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 47: GERMANY: ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 48: GERMANY: ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 49: U.K.: ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 50: U.K.: ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 51: FRANCE: ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 52: FRANCE: ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 53: ITALY: ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 54: ITALY: ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 55: SPAIN: ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 56: SPAIN: ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 57: ROE: ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 58: ROE: ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 59: ASIA: ALLERGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 60: ASIA: ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 61: ASIA: ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2014-2021 (USD MILLION)
  • TABLE 62: ASIA: ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGEN, 2014-2021 (USD MILLION)
  • TABLE 63: ASIA: ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 64: CHINA: ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 65: CHINA: ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 66: JAPAN: ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 67: JAPAN: ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 68: INDIA: ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 69: INDIA: ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 70: ROA: ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 71: ROA: ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 72: ROW: ALLERGY DIAGNOSTICS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 73: ROW: ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 74: ROW: ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST, 2014-2021 (USD MILLION)
  • TABLE 75: ROW: ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGEN, 2014-2021 (USD MILLION)
  • TABLE 76: ROW: ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 77: SOUTH AMERICA, CENTRAL AMERICA & THE CARIBBEAN: ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 78: SOUTH AMERICA, CENTRAL AMERICA & THE CARIBBEAN: ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 79: PACIFIC AND OCEANIA: ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 80: PACIFIC AND OCEANIA: ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 81: AFRICA: ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 82: AFRICA: ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 83: MARKET DEVELOPMENTS BETWEEN JANUARY 2012 AND MARCH 2016
  • TABLE 84: NEW PRODUCT LAUNCHES, 2012-2016
  • TABLE 85: EXPANSIONS, 2012-2016
  • TABLE 86: AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS, 2012-2016
  • TABLE 87: ACQUISITIONS, 2012-2016
  • TABLE 88: OTHER DEVELOPMENTS, 2012-2016

LIST OF FIGURES

  • FIGURE 1: GLOBAL ALLERGY DIAGNOSTICS MARKET
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4: ALLERGY DIAGNOSTICS MARKET: BOTTOM-UP APPROACH
  • FIGURE 5: ALLERGY DIAGNOSTICS MARKET: TOP-DOWN APPROACH
  • FIGURE 6: DATA TRIANGULATION METHODOLOGY
  • FIGURE 7: ALLERGY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2016 VS. 2021 (USD MILLION)
  • FIGURE 8: GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE OF ALLERGEN, 2016 VS 2021 (USD MILLION)
  • FIGURE 9: GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY TYPE OF TESTS, 2016 VS 2021 (USD MILLION)
  • FIGURE 10: GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2016 VS 2021 (USD MILLION)
  • FIGURE 11: GLOBAL ALLERGY DIAGNOSTICS MARKET, BY REGION, 2016 (USD MILLION)
  • FIGURE 12: GLOBAL ALLERGY DIAGNOSTICS MARKET TO WITNESS MODERATE GROWTH DURING THE FORECAST PERIOD
  • FIGURE 13: DIAGNOSTIC LABORATORIES SEGMENT TO DOMINATE THE ALLERGY DIAGNOSTICS MARKET IN 2016
  • FIGURE 14: ASIA TO WTINESS THE FASTEST GROWTH IN THE FORECAST PERIOD (2016-2021)
  • FIGURE 15: ASIAN MARKET SHOWCASES LUCRATIVE GROWTH OPPORTUNITIES
  • FIGURE 16: ALLERGY DIAGNOSTICS MARKET SEGMENTATION
  • FIGURE 17: HIGH INCIDENCES AND LARGE ECONOMIC BURDEN OF ALLERGIC DISEASES WILL DRIVE THE ALLERGY DIAGNOSTICS MARKET DURING THE FORECAST PERIOD
  • FIGURE 18: RISING ENVIRONMENTAL POLLUTION ACROSS THE GLOBE (2010 VS. 2011)
  • FIGURE 19: INCREASING HEALTHCARE EXPENDITURE IS A CRUCIAL FACTOR DRIVING THE GROWTH OF THE ALLERGY DIAGNOSTICS MARKET
  • FIGURE 20: GROWTH IN HEALTHCARE EXPENDITURE IN ASIA AND ROW OUTPACING THAT IN AMERICAS AND EUROPE
  • FIGURE 21: PORTER'S FIVE FORCES ANALYSIS (2016): PRESENCE OF LARGE NUMBER OF MANUFACTURING FIRMS INCREASES COMPETITION
  • FIGURE 22: MAJOR VALUE IS ADDED DURING MANUFACTURING AND ASSEMBLY PHASE
  • FIGURE 23: DIRECT DISTRIBUTION-STRATEGY PREFERRED BY PROMINENT COMPANIES
  • FIGURE 24: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT
  • FIGURE 25: ASSAY KITS TO FORM THE LARGEST PRODUCT SEGMENT IN 2016
  • FIGURE 26: NORTH AMERICA TO DOMINATE THE ALLERGY DIAGNOSTICS ASSAY KITS MARKET IN 2016
  • FIGURE 27: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET SIZE, BY TYPE, 2016 (USD MILLION)
  • FIGURE 28: NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE ALLERGY DIAGNOSTICS INSTRUMENTS MARKET IN 2016
  • FIGURE 29: NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE IMMUNOASSAY ANALYZERS MARKET IN 2016
  • FIGURE 30: NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE LUMINOMETERS MARKET IN 2016
  • FIGURE 31: NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE ELISA ANALYZERS MARKET IN 2016
  • FIGURE 32: NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE OTHER INSTRUMENTS MARKET IN 2016
  • FIGURE 33: NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE ALLERGY DIAGNOSTICS SERVICES MARKET IN 2016
  • FIGURE 34: ALLERGY DIAGNOSTICS MARKET SEGMENTATION, BY ALLERGENS
  • FIGURE 35: INHALED ALLERGENS TO BE THE LARGEST ALLERGEN SEGMENT IN 2016
  • FIGURE 36: ANIMAL ORIGIN TO BE THE LARGEST TYPE SEGMENT IN INHALED ALLERGEN MARKET IN 2016
  • FIGURE 37: NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE INHALED ALLERGENS SEGMENT IN 2016
  • FIGURE 38: PLANT ORIGIN TO BE THE LARGEST TYPE SEGMENT IN FOOD ALLERGEN MARKET IN 2016
  • FIGURE 39: NORTH AMERICA TO DOMINATE THE MARKET FOR FOOD ALLERGENS IN 2016
  • FIGURE 40: NORTH AMERICA TO COMMAND THE LARGEST SHARE OF DRUG ALLERGENS SEGMENT IN 2016
  • FIGURE 41: NORTH AMERICA TO DOMINATE THE ALLERGY DIAGNOSIS MARKET FOR OTHER ALLERGENS IN 2016
  • FIGURE 42: ALLERGY DIAGNOSTICS MARKET SEGMENTATION, BY TEST
  • FIGURE 43: IN VIVO TESTS TO FORM THE LARGEST TEST SEGMENT IN 2016
  • FIGURE 44: NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE IN VIVO ALLERGY TESTING MARKET IN 2016
  • FIGURE 45: NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE IN VITRO ALLERGY TESTING MARKET IN 2016
  • FIGURE 46: ALLERGY DIAGNOSTICS MARKET SEGMENTATION, BY END USER
  • FIGURE 47: ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2016 (USD MILLION)
  • FIGURE 48: NORTH AMERICA TO DOMINATE THE ALLERGY DIAGNOSTICS MARKET FOR DIAGNOSTIC LABORATORIES IN 2016
  • FIGURE 49: NORTH AMERICA TO DOMINATE THE ALLERGY DIAGNOSTICS MARKET FOR HOSPITALS BETWEEN 2016 AND 2021
  • FIGURE 50: ALLERGY DIAGNOSTICS MARKET FOR ACADEMIC RESEARCH INSTITUTES TO WITNESS HIGHEST GROWTH IN ASIA BETWEEN 2016 AND 2021
  • FIGURE 51: NORTH AMERICA TO DOMINATE THE ALLERGY DIAGNOSTICS MARKET FOR OTHER END USERS BETWEEN 2016 AND 2021
  • FIGURE 52: ALLERGY DIAGNOSTICS MARKET, BY REGION (MARKET SIZE AND GROWTH RATE), 2016-2021
  • FIGURE 53: ALLERGY DIAGNOSTICS MARKET IN ASIA EXPECTED TO GROW AT THE HIGHEST RATE (2016 TO 2021)
  • FIGURE 54: NORTH AMERICA: MARKET SNAPSHOT
  • FIGURE 55: U.S. TO DOMINATE THE NORTH AMERICAN ALLERGY DIAGNOSTICS MARKET
  • FIGURE 56: ASSAY KITS ESTIMATED TO BE THE LARGEST PRODUCT SEGMENT IN THE NORTH AMERICAN ALLERGY DIAGNOSTICS MARKET IN 2016
  • FIGURE 57: IN VIVO TESTS ESTIMATED TO BE THE LARGEST SEGMENT IN THE NORTH AMERICAN ALLERGY DIAGNOSTICS MARKET IN 2016
  • FIGURE 58: INHALED ALLERGENS TO ACCOUNT FOR THE LARGEST SHARE OF THE MARKET, BY ALLERGEN TYPE, IN NORTH AMERICA (2016)
  • FIGURE 59: DIAGNOSTIC LABORATORIES TO ACCOUNT FOR THE LARGEST SHARE OF THE MARKET, BY END USER, IN NORTH AMERICA
  • FIGURE 60: ASSAY KITS ESTIMATED TO BE THE LARGEST PRODUCT SEGMENT IN THE U.S. ALLERGY DIAGNOSTICS MARKET IN 2016
  • FIGURE 61: DIAGNOSTIC LABORATORIES TO ACCOUNT FOR THE LARGEST SHARE OF THE END-USER MARKET IN THE U.S.
  • FIGURE 62: GERMANY IS ESTIMATED TO DOMINATE THE EUROPEAN ALLERGY DIAGNOSTICS MARKET IN 2016
  • FIGURE 63: ASSAY KITS ESTIMATED TO BE THE LARGEST PRODUCT SEGMENT IN THE EUROPEAN ALLERGY DIAGNOSTICS MARKET IN 2016
  • FIGURE 64: IN VIVO TESTS ESTIMATED TO BE THE LARGEST SEGMENT IN THE EUROPEAN ALLERGY DIAGNOSTICS MARKET IN 2016
  • FIGURE 65: INHALED ALLERGENS TO ACCOUNT FOR THE LARGEST SHARE OF THE ALLERGEN IN EUROPE ALLERGY DIAGNOSTICS MARKET IN 2016
  • FIGURE 66: DIAGNOSTIC LABORATORIES TO ACCOUNT FOR THE LARGEST SHARE OF THE END-USER MARKET IN EUROPE
  • FIGURE 67: ASSAY KITS ESTIMATED TO BE THE LARGEST PRODUCT SEGMENT IN THE GERMAN ALLERGY DIAGNOSTICS MARKET IN 2016
  • FIGURE 68: DIAGNOSTIC LABORATORIES TO ACCOUNT FOR THE LARGEST SHARE OF THE END-USER MARKET IN GERMANY
  • FIGURE 69: ASIA: MARKET SNAPSHOT
  • FIGURE 70: CHINA IS ESTIMATED TO DOMINATE THE ASIAN ALLERGY DIAGNOSTICS MARKET IN 2016
  • FIGURE 71: ASSAY KITS ESTIMATED TO BE THE LARGEST PRODUCT SEGMENT IN ASIAN ALLERGY DIAGNOSTICS MARKET IN 2016
  • FIGURE 72: IN VIVO TESTS ESTIMATED TO BE THE LARGEST SEGMENT IN THE ASIAN ALLERGY DIAGNOSTICS MARKET IN 2016
  • FIGURE 73: INHALED ALLERGENS TO ACCOUNT FOR THE LARGEST SHARE OF THE ALLERGEN IN ASIAN ALLERGY DIAGNOSTICS MARKET IN 2016
  • FIGURE 74: DIAGNOSTIC LABORATORIES TO ACCOUNT FOR THE LARGEST SHARE OF THE END-USER MARKET IN ASIA
  • FIGURE 75: ASSAY KITS ESTIMATED TO BE THE LARGEST PRODUCT SEGMENT IN CHINESE ALLERGY DIAGNOSTICS MARKET IN 2016
  • FIGURE 76: DIAGNOSTIC LABORATORIES TO ACCOUNT FOR THE LARGEST SHARE OF THE END-USER MARKET IN CHINA
  • FIGURE 77: SOUTH AMERICA, CENTRAL AMERICA, AND THE CARIBBEAN IS ESTIMATED TO DOMINATE THE ROW ALLERGY DIAGNOSTICS MARKET IN 2016
  • FIGURE 78: ASSAY KITS ESTIMATED TO BE THE LARGEST PRODUCT SEGMENT IN THE ROW ALLERGY DIAGNOSTICS MARKET IN 2016
  • FIGURE 79: IN VIVO TESTS ESTIMATED TO BE THE LARGEST SEGMENT IN ROW ALLERGY DIAGNOSTICS MARKET IN 2016
  • FIGURE 80: INHALED ALLERGENS TO ACCOUNT FOR THE LARGEST SHARE OF THE ALLERGEN IN ROW ALLERGY DIAGNOSTICS MARKET IN 2016
  • FIGURE 81: DIAGNOSTIC LABORATORIES TO ACCOUNT FOR THE LARGEST SHARE OF THE END-USER MARKET IN ROW
  • FIGURE 82: ASSAY KITS ESTIMATED TO BE THE LARGEST PRODUCT SEGMENT IN SOUTH AMERICA, CENTRAL AMERICA, AND THE CARIBBEAN ALLERGY DIAGNOSTICS MARKET IN 2016
  • FIGURE 83: DIAGNOSTIC LABORATORIES TO ACCOUNT FOR THE LARGEST SHARE OF THE END-USER MARKET IN SOUTH AMERICA, CENTRAL AMERICA & THE CARIBBEAN
  • FIGURE 84: NEW PRODUCT LAUNCH AND EXPANSIONS WERE THE KEY STRATEGIES ADOPTED BY PLAYERS IN THE ALLERGY DIAGNOSTICS MARKET
  • FIGURE 85: ALLERGY DIAGNOSTICS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2015
  • FIGURE 86: FINANCIAL PERFORMANCES OF THE LEADING MARKET PLAYERS
  • FIGURE 87: COMPANY SNAPSHOT: BIOMERIEUX
  • FIGURE 88: COMPANY SNAPSHOT: DANAHER CORPORATION
  • FIGURE 89: COMPANY SNAPSHOT: HITACHI CHEMICAL DIAGNOSTICS, INC.
  • FIGURE 90: COMPANY SNAPSHOT: SIEMENS AG
  • FIGURE 91: COMPANY SNAPSHOT: THERMO FISHER SCIENTIFIC, INC.
  • FIGURE 92: COMPANY SNAPSHOT: OMEGA DIAGNOSTICS GROUP PLC
  • FIGURE 93: COMPANY SNAPSHOT: STALLERGENES GREER
Back to Top